Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07395128 · ClinicalTrials.gov registry record · Phase 1
Lateral Plantar Artery Embolization For Plantar Fasciitis
A Phase 1 study of Plantar Fasciitis and Plantar Fasciitis, Chronic, sponsored by Joint & Vascular Institute.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07395128 is a Phase 1 study of Plantar Fasciitis and Plantar Fasciitis, Chronic that is actively recruiting participants, run by Joint & Vascular Institute. The registered enrollment target is 10 participants, below the 107-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07395128, a Phase 1 study of Plantar Fasciitis and Plantar Fasciitis, Chronic, is actively recruiting participants, sponsored by Joint & Vascular Institute.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are: Does this procedure successfully reduce chronic heel pain as measured by the Visual Analog Scale (VAS) over 12 months? How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device? Participants will: Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels in the foot. Receive a phone call one day after the procedure to check for early side effects. Participate in four follow-up telehealth visits over the course of one year (at 1, 3, 6, and 12 months). Complete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.
Conditions Studied
Interventions
- DEVICE Lipiodol
Study Locations (1)
Illinois
- Joint and Vascular Institute - Libertyville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-12-20 |
| Est. Completion | 2027-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07395128
The ClinicalTrials.gov registry entry for NCT07395128 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 107-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (91% lower). The listed sponsor is Joint & Vascular Institute, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Plantar Fasciitis appearing as the primary indexed condition, and to 1 intervention - of which Lipiodol is the first listed.
NCT07395128 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07395128 about?
NCT07395128 is a clinical study titled "Lateral Plantar Artery Embolization For Plantar Fasciitis". The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are: Does this procedure successfully reduce chronic heel pain ...
What is the current status of trial NCT07395128?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-12-20. Estimated completion is 2027-03.
What conditions does trial NCT07395128 study?
This clinical trial studies the following conditions: Plantar Fasciitis, Plantar Fasciitis, Chronic.
What interventions are being tested in trial NCT07395128?
The interventions under investigation include: Lipiodol (DEVICE).
Who is sponsoring clinical trial NCT07395128?
This trial is sponsored by Joint & Vascular Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07395128 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fasciitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
RECRUITING · NA
-
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
COMPLETED · Phase 2
-
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
COMPLETED · Phase 4
-
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
COMPLETED · Phase 3
-
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
COMPLETED · Phase 2
-
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.